TORNTPHARM.BOTORNTPHARM.BO
LOADING
|||
EPS Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
7.78%
↓ 47% below average
Average (39q)
14.75%
Historical baseline
Range
High:400.57%
Low:-161.93%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 7.78% |
| Q2 2025 | 10.06% |
| Q1 2025 | -1.14% |
| Q4 2024 | 11.29% |
| Q3 2024 | -0.96% |
| Q2 2024 | 1.73% |
| Q1 2024 | 1.38% |
| Q4 2023 | 14.72% |
| Q3 2023 | 2.15% |
| Q2 2023 | 31.72% |
| Q1 2023 | 1.44% |
| Q4 2022 | -9.33% |
| Q3 2022 | -11.85% |
| Q2 2022 | 400.57% |
| Q1 2022 | -147.22% |
| Q4 2021 | -20.92% |
| Q3 2021 | -4.61% |
| Q2 2021 | 2.30% |
| Q1 2021 | 9.02% |
| Q4 2020 | -4.37% |
| Q3 2020 | -3.48% |
| Q2 2020 | 2.37% |
| Q1 2020 | 25.44% |
| Q4 2019 | 2.07% |
| Q3 2019 | 13.66% |
| Q2 2019 | 241.87% |
| Q1 2019 | -161.93% |
| Q4 2018 | 37.05% |
| Q3 2018 | 9.52% |
| Q2 2018 | -28.76% |
| Q1 2018 | 301.18% |
| Q4 2017 | -72.02% |
| Q3 2017 | 9.03% |
| Q2 2017 | -9.03% |
| Q1 2017 | -9.64% |
| Q4 2016 | 9.95% |
| Q3 2016 | -29.05% |
| Q2 2016 | 2.73% |
| Q1 2016 | -2.21% |
| Q4 2015 | -42.70% |